Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production.
Bordetella pertussis infection has been increasing in the US, with reported cases reaching over 50,000 in 2012, a number last observed in the 1950s. Concurrently, B. pertussis lacking the pertactin protein, one of the immunogens included in the acellular vaccine formulations, has rapidly emerged sin...
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Public Library of Science (PLoS)
2017-01-01
|
| Collection: | PLoS ONE |
| Accès en ligne: | http://europepmc.org/articles/PMC5386250?pdf=render |